Advisor Group Holdings, Inc. Harpoon Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.55 - $0.82 $565 - $842	-1,028 Reduced 49.0%	1,070 $0
Q1 2023 May 12, 2023	BUY	$0.65 - $1.37 $368 - $776	567 Added 37.03%	2,098 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.6 - $1.41 $509 - $1,197	849 Added 124.49%	1,531 $1,000
Q2 2022 Aug 10, 2022	SELL	$1.78 - $5.02 $386 - $1,089	-217 Reduced 24.14%	682 $1,000
Q1 2022 May 04, 2022	BUY	$3.54 - $8.08 $3,182 - $7,263	899 New	899 $3,000
Q4 2020 Feb 10, 2021	SELL	$12.83 - $17.84 $9,622 - $13,380	-750 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.11 - $24.72 $8,332 - $18,540	750 New	750 $12,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.